DK0506716T3 - Fremgangsmåde til behandling af trombocytopeni og farmaceutiske præparater egnet dertil - Google Patents

Fremgangsmåde til behandling af trombocytopeni og farmaceutiske præparater egnet dertil

Info

Publication number
DK0506716T3
DK0506716T3 DK91900679.1T DK91900679T DK0506716T3 DK 0506716 T3 DK0506716 T3 DK 0506716T3 DK 91900679 T DK91900679 T DK 91900679T DK 0506716 T3 DK0506716 T3 DK 0506716T3
Authority
DK
Denmark
Prior art keywords
pct
pharmaceutical compositions
compositions suitable
treating thrombocytopenia
sec
Prior art date
Application number
DK91900679.1T
Other languages
English (en)
Inventor
Donald Metcalf
Original Assignee
Amrad Corp Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amrad Corp Ltd filed Critical Amrad Corp Ltd
Application granted granted Critical
Publication of DK0506716T3 publication Critical patent/DK0506716T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/20Interleukins [IL]
    • A61K38/2093Leukaemia inhibitory factor [LIF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK91900679.1T 1989-12-18 1990-12-18 Fremgangsmåde til behandling af trombocytopeni og farmaceutiske præparater egnet dertil DK0506716T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPJ791289 1989-12-18
AUPK350190 1990-11-23

Publications (1)

Publication Number Publication Date
DK0506716T3 true DK0506716T3 (da) 1996-02-26

Family

ID=25643793

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91900679.1T DK0506716T3 (da) 1989-12-18 1990-12-18 Fremgangsmåde til behandling af trombocytopeni og farmaceutiske præparater egnet dertil

Country Status (12)

Country Link
US (1) US5571508A (da)
EP (1) EP0506716B1 (da)
JP (1) JP2574962B2 (da)
AT (1) ATE128871T1 (da)
CA (1) CA2071956C (da)
DE (1) DE69023006T2 (da)
DK (1) DK0506716T3 (da)
ES (1) ES2078501T3 (da)
FI (1) FI922839A0 (da)
GR (1) GR3017727T3 (da)
HU (2) HUT61485A (da)
WO (1) WO1991008752A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6251864B1 (en) 1995-06-07 2001-06-26 Glaxo Group Limited Peptides and compounds that bind to a receptor
EP2055712A1 (en) 1995-06-07 2009-05-06 Glaxo Group Limited Peptides and compounds that bind to a thrombopoietin receptor
US5869451A (en) * 1995-06-07 1999-02-09 Glaxo Group Limited Peptides and compounds that bind to a receptor
US7091311B2 (en) 1996-06-07 2006-08-15 Smithkline Beecham Corporation Peptides and compounds that bind to a receptor
MXPA05003057A (es) 2002-09-18 2006-04-18 Johnson & Johnson Metodos para aumentar la produccion de celulas madre hematopoyeticas y plaquetas.
HUE032370T2 (en) 2003-08-28 2017-09-28 Janssen Pharmaceuticals Inc Peptides and compounds that bind to thrombopoietin receptors
US7723295B2 (en) 2003-08-28 2010-05-25 Ortho-Mcneil Pharmaceutical, Inc. Peptides and compounds that bind to a receptor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4859648A (en) * 1984-12-28 1989-08-22 Mobil Oil Corporation Layered metal chalcogenides containing interspathic polymeric chalcogenides
AU609128B2 (en) * 1987-04-02 1991-04-26 Amrad Operations Pty. Limited Leukaemia-inhibitory factor
WO1990002183A1 (en) * 1988-08-18 1990-03-08 Genetics Institute, Inc. Production of a novel lymphokine exhibiting differentiation inhibitory activity
JP2805224B2 (ja) * 1989-01-13 1998-09-30 味の素株式会社 血小板減少症治療剤
US5435999A (en) * 1989-11-24 1995-07-25 Monash University Proliferative action of leukaemia inhibitory factor on satellite cells

Also Published As

Publication number Publication date
DE69023006D1 (de) 1995-11-16
DE69023006T2 (de) 1996-04-11
WO1991008752A1 (en) 1991-06-27
AU6910491A (en) 1991-07-18
JP2574962B2 (ja) 1997-01-22
GR3017727T3 (en) 1996-01-31
EP0506716A1 (en) 1992-10-07
ATE128871T1 (de) 1995-10-15
EP0506716A4 (en) 1993-05-05
AU644834B2 (en) 1993-12-23
CA2071956A1 (en) 1991-06-19
US5571508A (en) 1996-11-05
FI922839A (fi) 1992-06-17
EP0506716B1 (en) 1995-10-11
CA2071956C (en) 2000-04-18
HU210882A9 (en) 1995-09-28
JPH05502667A (ja) 1993-05-13
ES2078501T3 (es) 1995-12-16
HU9202026D0 (en) 1992-09-28
FI922839A0 (fi) 1992-06-17
HUT61485A (en) 1993-01-28

Similar Documents

Publication Publication Date Title
ATE148130T1 (de) Typ-iv-dipeptidyl-aminopeptidase-inhibitoren
YU64092A (sh) Fluoralkoksibenzamino derivati heterocikličnih jedinjenja koja sadrže azot
DK0675708T3 (da) Farmaceutiske og dermokosmetiske sammensætninger indeholdende heste-colostrum.
DK0581959T3 (da) Anvendelse af makrolidforbindelser til øjensygdomme
ATE107515T1 (de) Zusammensetzung zur behandlung von entzündung.
DK0589995T3 (da) Hidtil ukendte polypeptider og deres anvendelse
DK0706514T3 (da) Forbindelser og fremgangsmåder til inhibering af HIV og relaterede vira
DK0506716T3 (da) Fremgangsmåde til behandling af trombocytopeni og farmaceutiske præparater egnet dertil
DE68918944D1 (de) Künstliche rezeptor-analoge.
DK0722325T3 (da) Præparat til behandling eller forebyggelse af herpes
ATE183100T1 (de) Neuartige glukohydrolase-inhibitoren nützlich als antidiabetische, antivirale und antimetastatische mittel
DK0497906T3 (da) L-alfa-glycerophosphoryl-D-myo-inositol til behandling af perifere neuropatier og cerebropatier
NO922341L (no) Fremgangsmaate og middel for behandling av trombocytopeni
DK0539465T3 (da) Anvendelse af 20(R)-22-oxa-D-vitamin-analoger til fremstilling af et farmaceutisk præparat til behandling og/eller forebyggelse af hudaldring
ES2150494T3 (es) Derivados sustituidos de quinolina y su utilizacion como inhibidores de la secrecion de acido gastrico.
DK0673377T3 (da) Nye triazoloquinazoliner, fremstilling og anvendelse deraf
DK0703916T3 (da) 14-Substituerede marcfortiner og derivater, der kan anvendes som antispirant-midler
ATE232724T1 (de) Inhibitor von stickstoffmonoxid (no) synthase zur verhütung von typ ii diabetes
ES2065951T3 (es) Uso de un inhibidor de prolilendopeptidasa para el tratamiento del sida.
DK0971714T3 (da) Metode til anvendelse af cyklooxygenase-2-inhibitorer til behandling og forebyggelse af demens
SE9304065D0 (sv) New compound